[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR100369410B1 - A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE - Google Patents

A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE Download PDF

Info

Publication number
KR100369410B1
KR100369410B1 KR10-1999-0065777A KR19990065777A KR100369410B1 KR 100369410 B1 KR100369410 B1 KR 100369410B1 KR 19990065777 A KR19990065777 A KR 19990065777A KR 100369410 B1 KR100369410 B1 KR 100369410B1
Authority
KR
South Korea
Prior art keywords
compound
formula
prepared
reaction
peg
Prior art date
Application number
KR10-1999-0065777A
Other languages
Korean (ko)
Other versions
KR20010065821A (en
Inventor
박대규
Original Assignee
조선무약합자회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조선무약합자회사 filed Critical 조선무약합자회사
Priority to KR10-1999-0065777A priority Critical patent/KR100369410B1/en
Publication of KR20010065821A publication Critical patent/KR20010065821A/en
Application granted granted Critical
Publication of KR100369410B1 publication Critical patent/KR100369410B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

출발물질인 시클로펜타데칸-1-온 화합물을 무수 시클로-헥산, 파라-톨루엔설폰산 촉매하에서 가열하여 생성되는 물을 제거하면서 케탈화 반응을 진행하여 시클로펜타데칸-1-온 에틸렌케탈 화합물을 제조하고, 얻어진 화합물을 무수 테트라히드로푸란 중에서 페닐트리메칠암모늄트리브로마이드를 사용하여 2-브로모시클로펜타데칸-1-온 에틸렌케탈 화합물을 제조한후, 얻은 화합물을 디메칠 설폭사이드와 PEG 존재하에서 수산화나트륨을 사용하여 2-시클로펜타데센-1-온 에틸렌케탈 화합물을 제조한 후, 얻어진 화합물을 실온에서 아세톤과 물 중에서 황산마그네슘-옥살산 수화물을 산촉매로 사용하여 2-시클로펜타데센-1-온 화합물을 제조하고, 이어서 얻어진 화합물을 -40∼0 ℃의 무수 톨루엔중에서 요오드화제일동을 촉매로 사용하면서 반응화합물과 메칠리튬 또는 메칠마그네슘브로마이드를 일정량씩 분할하여 교대로 첨가함을 특징으로하는 디엘-3-메칠-시클로펜타데칸-1-온 화합물을 고수율, 고순도로 제조하는 방법.A cyclopentadecan-1-one ethylene ketal compound was prepared by carrying out a ketalization reaction while removing the water produced by heating the starting cyclopentadecan-1-one compound under anhydrous cyclo-hexane and para-toluenesulfonic acid catalyst. The obtained compound was prepared in anhydrous tetrahydrofuran using phenyltrimethylammoniumtribromide to prepare a 2-bromocyclopentadecan-1-one ethylene ketal compound, and then the obtained compound was hydroxylated in the presence of dimethyl sulfoxide and PEG. After preparing a 2-cyclopentadeceen-1-one ethylene ketal compound using sodium, the obtained compound was used as an acid catalyst using magnesium sulfate-oxalic acid hydrate as an acid catalyst in acetone and water at room temperature. Was prepared, and the obtained compound was reacted with the reaction compound in anhydrous toluene at -40 to 0 ° C while using the same iodide as a catalyst. Method for producing a high-cyclopenta-decane-1-one compound in high yield, high purity - seven lithium or a methyl magnesium bromide, methyl DL-3, characterized in that the shift is added to the division by a predetermined amount.

Description

디엘-3-메칠-시클로펜타데칸-1-온의 제조방법 {A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE}Method for preparing DL-3-methyl-cyclopentadecan-1-one {A PROCESS FOR THE PREPARATION OF d, l-3-METHYL-CYCLOPENTADECAN-1-ONE}

본 발명은 중추신경계에 작용하는 구조식(Ⅰ)로 표시되는 디엘-3-메칠-시클로 펜타데칸-1-온의 개량된 제조방법에 관한 것이다.The present invention relates to an improved process for the preparation of DL-3-methyl-cyclopentadecan-1-one represented by structural formula (I) which acts on the central nervous system.

일반적으로 상기 구조식(Ⅰ)로 표시되는 디엘-3-메칠-시클로 펜타데칸-1-온 (d,l-3-methyl-cyclopentadecan-1-one)은 중추신경계 및 심.순환계등에 작용하는 의약용화합물로서, 이들 중 엘-3-메칠-시클로 펜타데칸-1-온은 현재 우황청심원등의 사향 대체물질로서 널리 사용되고 있으므로 디엘-3-메칠-시클로 펜타데칸-1-온은 이의 전구물질 또는 대체물질로서의 역할이 기대되는 물질이다.In general, dl-3-methyl-cyclopentadecan-1-one (d, l-3-methyl-cyclopentadecan-1-one) represented by Structural Formula (I) is a pharmaceutical agent acting on the central nervous system and the cardiovascular system. As a compound, among them, L-3-methyl-cyclo pentadecane-1-one is widely used as a musk substitute such as whey of sulfur, and thus, DL-methyl-cyclo pentadecane-1-one is a precursor or substitute thereof. It is expected to serve as a substance.

상기 구조식(I) 화합물의 제조를 위하여 공지방법이 많이 알려져 있으며, 예를들면, J.Org.Chem.36(26), 4124(1971)에는 시클로펜타데칸-1-온을 출발물질로하여 산촉매하에서 케탈화, 브롬화, 탈수소브롬화, 가수분해, 메칠화과정을 거쳐 상기 구조식(I)의 화합물을 제조하는 방법을 제시하였으나, 탈수소브롬화 반응시 사용되는 DBN(1,5-diazabicyclo[4.3.0] non-5-ene) 또는 DBU(1,8-diazabicyclo [5.4.0] undec-7-ene)가 매우 고가이며, 전체반응 수율이 50∼60 % 정도이고, 순도 또한 낮아 크로마토그래피법에 의한 분리, 정제를 행하여야만 하는 단점이 있다.There are many known methods for the preparation of the above compound of formula (I). For example, J. Org. Chem. 36 (26) and 4124 (1971) have an acid catalyst starting from cyclopentadecan-1-one as a starting material. Although a method of preparing the compound of formula (I) through ketalization, bromination, dehydrobromination, hydrolysis, and methylation under the present method, DBN (1,5-diazabicyclo [4.3.0] used in the dehydrogenation bromination reaction was proposed. non-5-ene) or DBU (1,8-diazabicyclo [5.4.0] undec-7-ene) is very expensive, the overall reaction yield is about 50-60%, and the purity is also low and separation by chromatography However, there is a disadvantage in that purification should be performed.

이에 본 발명자는 상기와 같은 종래의 기술방법상의 문제점들을 해결하기 위하여 장기간에 걸쳐 연구하여 온 결과, 상기 구조식(I) 화합물의 제조방법에 있어 크로마토그래피법등 별도의 정제방법을 행하지 않고도 수율 및 순도면에서 상당히 개선된 제조방법을 발명하여 특허 제196888호(1999.2.18.등록)를 획득한바 있다.Accordingly, the present inventors have been studying for a long time to solve the problems of the conventional technical method as described above, in the production method of the compound of formula (I), the yield and net without performing a separate purification method such as chromatography method Invented a significantly improved manufacturing method in the drawing to obtain a patent No. 196888 (registered on Feb. 1999).

그러나, 상기 특허 방법은 수율 및 순도면에서는 개선을 보이나 여전히 몇가지 문제점을 안고 있는데,However, the patented method shows improvement in yield and purity but still has some problems.

1)케탈화반응 수행시 가열조건하 반응용매로 사용하는 무수벤젠은 인체에 유해성이 커서 취급하기가 까다롭고,1) Anhydrous benzene, which is used as a reaction solvent under heating conditions in the ketalization reaction, is difficult to handle because it is harmful to the human body.

2)탈수소브롬화반응 수행시 고가의 알콕사이드와 같은 강염기를 사용하고 있어 제조원가가 높은 단점이 있고, 반응종결후 바람직하지 않은 부산물이 생성되며,2) The use of strong bases such as expensive alkoxides in the dehydrogenation bromide reaction has the disadvantage of high manufacturing cost, and after the reaction is terminated, undesirable by-products are produced.

3)산촉매를 이용한 가수분해시 반응시간이 24시간 이상으로 장시간이 필요하였고,3) When hydrolysis using acid catalyst, the reaction time was longer than 24 hours,

4)메칠화반응 수행시 디에칠에테르를 사용하나 취급이 까다로울뿐만아니라반응시 사고의 위험이 높고, 반응종결후 바람직하지 않은 부산물이 생성되며, 촉매인 요드화제일동을 1.5∼2.5의 몰비율로 과량 사용하고 있어 제조원가에 미치는 영향이 큰 결점이 있었다.4) Using methyl ether when performing methylation reaction, it is not only difficult to handle but also has high risk of accident during the reaction, and undesirable by-products are produced after the reaction is completed. Excessive use has a significant effect on the manufacturing cost.

이에 본 발명자는 상기 인용특허에 기재된 방법보다 훨씬 개량된 새로운 제조방법을 발명하였기에, 이를 특허로서 출원하는 바이다.The present inventors have invented a new manufacturing method which is much improved than the method described in the cited patent, and is filed as a patent.

따라서, 본 발명은 인체에 유해성이 큰 용매의 사용을 회피하여 반응공정상의 안전성을 확보하고, 반응시간을 단축시키며, 알콕사이드 또는 요오드화제일동등의 고가시약의 사용량을 줄임으로써, 원가면에서 향상된 상기 구조식(Ⅰ)의 화합물을 고수율.고순도를 유지하며, 공업적으로 대량생산이 가능한, 새로운 제조방법을 제공하는 것을 그 목적으로 하고 있다.Accordingly, the present invention avoids the use of a solvent that is harmful to the human body to ensure the safety of the reaction process, to shorten the reaction time, and to reduce the amount of expensive reagents such as alkoxides or iodide iodide, improved structural formula in terms of cost It is an object of the present invention to provide a new production method for maintaining the high yield and high purity of the compound of (I) and enabling industrial mass production.

이하, 본 발명의 기술구성을 구조식과 함께 설명하면 다음과 같다.Hereinafter, the technical configuration of the present invention with the structural formula as follows.

출발물질인 구조식(Ⅱ)의 시클로펜타데칸-1-온 화합물을 무수 시클로-헥산에 용해시킨후, 파라-톨루엔 설폰산 촉매하에서 가열하여 생성되는 물을 제거하면서 케탈화반응을 진행하여 구조식(Ⅲ)의 시클로펜타데칸-1-온 에틸렌케탈 화합물을 제조하고, 얻어진 구조식(Ⅲ) 화합물을 무수 테트라히드로푸란 중에서 페닐트리메칠암모늄트리브로마이드(이하 "PTT"라 칭함)와 브롬화 반응시켜 구조식(Ⅳ)의 2-브로모시클로펜타데칸-1-온-에틸렌케탈 화합물을 제조한후, 얻은 구조식(Ⅳ) 화합물을 디메칠설폭사이드와 폴리에틸렌글리콜(PEG) 존재하에서 수산화나트륨과 같은 염기를 사용하여 탈수소브롬화반응을 시켜 구조식(Ⅴ)의 2-시클로펜타데센-1-온 에틸렌케탈 화합물을 제조한 후, 얻어진 구조식(Ⅴ)화합물을 실온에서 아세톤과 물중에서 황산마그네슘과 옥살산 수화물을 산촉매로 사용하여 가수분해시켜 구조식(Ⅵ)의 2-시클로펜타데센-1-온 화합물을 제조하고, 이어서 제조한 구조식(Ⅵ)의 화합물을 -40∼0 ℃의 무수 톨루엔중에서 요오드화제일동을 촉매로 사용하면서 구조식(Ⅵ)의 화합물과 메칠리튬 또는 메칠마그네슘브로마이드를 일정량씩 분할하여 교대로 첨가함으로써 메칠화반응을 진행시켜 구조식(Ⅰ)의 화합물을 제조하는 방법으로 별도의 정제과정 없이 안전하고 저렴하게 고수율, 고순도로 목적물을 얻는 것이다.The cyclopentadecane-1-one compound of Structural Formula (II), which is a starting material, was dissolved in anhydrous cyclo-hexane and then subjected to a ketalization reaction while removing water produced by heating under a para-toluene sulfonic acid catalyst. Cyclopentadecan-1-one ethylene ketal compound was prepared, and the obtained structural formula (III) compound was brominated with phenyltrimethylammoniumtribromide (hereinafter referred to as "PTT") in anhydrous tetrahydrofuran to give structural formula (IV) 2-bromocyclopentadecan-1-one-ethylene-ketal compound was prepared, and then the obtained structural formula (IV) compound was dehydrogenated using a base such as sodium hydroxide in the presence of dimethylsulfoxide and polyethylene glycol (PEG). After the reaction to prepare 2-cyclopentadeceen-1-one ethylene ketal compound of formula (V), the obtained compound of formula (V) was reacted with magnesium sulfate and jade in acetone and water at room temperature. Hydrolysis Using Salmonic Acid Hydrate as Acid Catalyst to Prepare 2-cyclopentadeceen-1-one Compound of Structural Formula (VI), and then the Compound of Structural Formula (VI) Prepared in Anhydrous Toluene at -40 to 0 ° C. Using copper as a catalyst, a compound of structural formula (VI) and methyllithium or methylmagnesium bromide are added in alternating amounts to be added in alternating manner to proceed with methylation to prepare the compound of structural formula (I). Safe and inexpensive high yield, high purity to get the target.

이하, 본 발명을 좀더 자세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in more detail.

구조식(II)의 시클로 펜타데칸-1-온을 무수 시클로-헥산에 용해시키고 에칠렌글리콜과 파라-톨루엔설폰산 수화물를 넣고 생성되는 물을 제거하면서 가열.교반한다.The cyclo pentadecane-1-one of formula (II) is dissolved in anhydrous cyclo-hexane, added with ethylene glycol and para-toluenesulfonic acid hydrate, and heated and stirred while removing the resulting water.

반응종결후 무수 시클로-헥산을 사용해 에칠렌글리콜층을 추출하여 구조식 (III)의 화합물을 고수율(100 %), 고순도(98.6 %)로 얻었다.After completion of the reaction, the ethylene glycol layer was extracted using anhydrous cyclo-hexane to obtain the compound of formula (III) in high yield (100%) and high purity (98.6%).

이 반응에서는 반응용매를 종래의 인체에 유해성이 큰 용매인 무수 벤젠에서 인체에 유해성이 적은 무수 시클로-헥산으로 변경함으로서 작업공정의 안전성면에서 개량된 제조방법으로 구조식(III)의 케탈화합물을 얻을 수 있었다.In this reaction, the ketal compound of formula (III) can be obtained by an improved manufacturing method in terms of safety of the work process by changing the reaction solvent from anhydrous benzene, which is a solvent that is harmful to the human body, to anhydrous cyclo-hexane, which is less harmful to the human body. Could.

이어서, 구조식(III)의 화합물을 무수 테트라히드로푸란에 용해시킨후, 무수 테트라히드로푸란에 용해시킨 PTT용액을 0 ℃에서 2 시간동안 적가하여 구조식(Ⅳ)의 브롬치환유도체 화합물을 고수율(100 %), 고순도(98 %)로 얻을 수 있었다.Subsequently, the compound of formula (III) was dissolved in anhydrous tetrahydrofuran, and then the PTT solution dissolved in anhydrous tetrahydrofuran was added dropwise at 0 ° C. for 2 hours to obtain the bromine substituted derivative compound of formula (IV) in high yield (100%). %), High purity (98%) was obtained.

이어서, 구조식(Ⅳ)의 화합물을 디메칠설폭사이드에 녹이고 염기와 폴리에틸렌글리콜(PEG)를 첨가하고 60∼80 ℃에서 교반하여 구조식(Ⅴ)의 화합물을 고순도 (98 %), 고수율(99 %)로 얻을 수 있었다.Subsequently, the compound of formula (IV) was dissolved in dimethyl sulfoxide, a base and polyethylene glycol (PEG) were added, and the mixture was stirred at 60 to 80 ° C. to give the compound of formula (V) with high purity (98%) and high yield (99%). Could get.

이 반응에서 염기의 종류로는, 수산화칼륨, 수산화리튬, 수산화나트륨등을 사용할 수 있으나 수산화나트륨이 가장 바람직하며, 사용량은 구조식(Ⅳ) 화합물 1몰에 대해 2∼3 배 몰이 가장 적당하며, 반응온도는 65∼70 ℃에서 7∼8 시간동안 반응시키는 것이 가장 바람직하다.In this reaction, as the kind of base, potassium hydroxide, lithium hydroxide, sodium hydroxide, etc. may be used, but sodium hydroxide is most preferred, and the amount of base used is 2-3 moles per mole of the compound of formula (IV). The temperature is most preferably reacted at 65 to 70 ° C. for 7 to 8 hours.

본 발명에서 사용하는 PEG의 종류로는 PEG-400, -600, -4000, -6000 등을 사용할 수 있으나 PEG-400 또는 -600의 사용이 바람직하며, 사용량은 구조식(Ⅳ) 화합물 1몰에 대해 10∼100배 몰 %을 사용할 수 있으나 30∼50배 몰 %를 사용하는 것이 가장 바람직하다.PEG-400, -600, -4000, -6000, etc. may be used as the type of PEG used in the present invention, but PEG-400 or -600 is preferably used, and the amount of PEG is used per 1 mole of the compound of formula (IV). 10 to 100 times mole% may be used but most preferably 30 to 50 times mole%.

수산화나트륨과 PEG의 사용량이 적으면 반응시간이 길어지고, 사용량이 많거나 반응온도가 높으면 순도가 떨어지는 단점이 있다.When the amount of sodium hydroxide and PEG is small, the reaction time is long, and when the amount is high or the reaction temperature is high, the purity is low.

이 반응에서 염기를 종래의 사용하기에 불편하고 고가인 알콕사이드를 저가인 무기금속의 수산화물로 변경함으로써 제조원가와 작업의 안전성 면에서 개량된 제조방법으로 구조식(Ⅴ) 화합물을 얻을 수 있었다.In this reaction, the compound of formula (V) was obtained by an improved production method in terms of production cost and safety of operation by changing base alkoxide, which is inconvenient to use conventionally and expensive alkoxide, to hydroxide of inorganic metal.

특히, 생성된 소량의 부산물의 제거가 용이하여 고순도의 물질을 확보할 수 있었다.In particular, the removal of a small amount of by-products can be easily obtained to ensure a high purity material.

이어서 구조식(Ⅴ)화합물에 산촉매를 사용해 가수분해하여 얻은 구조식(Ⅵ)의 화합물은 출발물질인 구조식(Ⅱ)의 화합물로부터 전체수율 95 %, 순도 97∼98 %로 얻을 수 있었다.Subsequently, the compound of formula (VI) obtained by hydrolysis using an acid catalyst to the compound of formula (V) was obtained in a total yield of 95% and a purity of 97-98% from the compound of formula (II) as a starting material.

이 반응에서의 산 촉매로써는 구조식(V)화합물 1몰에 대하여 황산마그네슘(10 몰 %)과 옥살산수화물(10 몰 %)을 사용하는 것이 가장 바람직하다.As the acid catalyst in this reaction, it is most preferable to use magnesium sulfate (10 mol%) and oxalic acid hydrate (10 mol%) with respect to 1 mol of the structural formula (V) compound.

종래에는 산촉매를 파라-톨루엔 설폰산 수화물(20 몰 %)을 사용하였으나 본 발명에서는 황산마그네슘(10 몰 %)과 옥살산수화물(10 몰 %)로 변경함으로서 반응시간을 24 시간에서 4∼5 시간으로 단축시킬 수 있었으며, 고순도의 구조식(Ⅵ)의 화합물을 고수율로 얻을 수 있었다.Conventionally, the acid catalyst was used as para-toluene sulfonic acid hydrate (20 mol%), but in the present invention, the reaction time was changed from 24 hours to 4 to 5 hours by changing to magnesium sulfate (10 mol%) and oxalic acid hydrate (10 mol%). The compound of formula (VI) of high purity was obtained in high yield.

이어서, 구조식(Ⅵ)의 화합물의 메칠화 반응은 무수 톨루엔에서 제일동화합물을 촉매로 사용하고, 구조식(Ⅵ)의 화합물과 메칠리튬 또는 메칠마그네슘브로마이드를 일정량씩 분할하여 교대로 첨가함으로써 구조식(I)의 화합물인 목적화합물을 제조한다.Subsequently, the methylation reaction of the compound of the formula (VI) is carried out by using the first copper compound as a catalyst in anhydrous toluene, and adding the compound of the formula (VI) and methyllithium or methylmagnesium bromide in alternating amounts to add the structural formula (I). To prepare the target compound, a compound of).

이 반응에서는 반응용매를 종래의 디에칠에테르에서 톨루엔으로 변경함으로서 작업상 안전성을 확보하고, 부산물의 생성을 줄임으로써 순도면에서 개량된 반응방법으로 구조식(Ⅰ)의 화합물을 얻었다.In this reaction, the compound of formula (I) was obtained by an improved reaction method in terms of purity by securing operational safety by reducing the reaction solvent from conventional ethyl ether to toluene and reducing the production of by-products.

제일동 화합물로써는 염화제일동, 요오드화제일동, 브롬화제일동, 시안화제일동 등을 사용할 수 있으나 요오드화 제일동이 바람직하다.Copper chloride, copper iodide, copper bromide, copper cyanide and the like may be used as the first copper compound, but copper iodide is preferred.

구조식(Ⅵ)의 화합물과 메칠리튬 또는 메칠마그네슘브로마이드를 일정량씩 분할하여, 즉 구조식(VI)화합물 1몰과 메칠리튬 또는 메칠마그네슘 브로마이드 0.25~0.62 당량씩 4회 교대로 첨가하는 방식으로 이를 설명하면 아래와 같다.This can be explained by dividing the compound of formula (VI) with methyllithium or methylmagnesium bromide by a predetermined amount, i.e., adding one mole of the compound of formula (VI) and four times with 0.25 to 0.62 equivalents of methyllithium or magnesium magnesium bromide. It looks like this:

우선, 무수 톨루엔에 0.25∼0.32 당량의 요오드화 제일동을 넣고 반응액의 온도를 0 ℃로 유지시키고 0.5∼0.62 당량의 메칠리튬 또는 메칠마그네슘브로마이드를 첨가한다.First, 0.25 to 0.32 equivalents of first copper iodide is added to anhydrous toluene, and the temperature of the reaction solution is maintained at 0 ° C, and 0.5 to 0.62 equivalents of methyllithium or methylmagnesium bromide are added.

반응액의 온도를 -20 ℃로 낮추고 무수 톨루엔에 녹인 구조식(Ⅵ)의 화합물 0.25 당량을 반응액에 30∼60 분간 첨가한다.The temperature of the reaction solution was lowered to -20 ° C and 0.25 equivalent of the compound of formula (VI) dissolved in anhydrous toluene was added to the reaction solution for 30 to 60 minutes.

첨가가 끝난후 반응액에 다시 0.25∼0.28 당량의 메칠리튬 또는 메칠마그네슘브로마이드를 첨가하고 무수 톨루엔에 녹인 구조식(Ⅵ)의 화합물 0.25 당량을 반응액에 30∼60 분간 첨가한다.After the addition, 0.25 to 0.28 equivalents of methyllithium or methylmagnesium bromide are added to the reaction solution, and 0.25 equivalents of the compound of formula (VI) dissolved in anhydrous toluene are added to the reaction solution for 30 to 60 minutes.

이후 위의 첨가조작을 2 회 반복하여 구조식(Ⅵ)의 화합물로부터 수율 99 %, 순도 96 %의 구조식(Ⅰ)의 화합물을 얻었다.Thereafter, the above addition operation was repeated twice to obtain a compound of formula (I) having a yield of 99% and a purity of 96% from the compound of formula (VI).

이 반응에서는 종래에는 요오드화제일동을 1.5∼2.5 몰의 비율로 사용하던 제조방법 대신 구조식(Ⅵ)의 화합물과 메칠리튬 또는 메칠마그네슘브로마이드를 분할하여 교대로 첨가함으로써 고가 촉매인 요오드화제일동의 소량(0.25 당량) 사용이 가능하며, 메칠리튬 또는 메칠마그네슘브로마이드의 사용량 역시 줄일 수 있어 원가면에서 개량된 제조방법으로 구조식(Ⅰ)의 목적화합물을 얻었다.In this reaction, a small amount of copper iodide, a high-priced catalyst (0.25), was added by dividing the compound of formula (VI) and methyllithium or methylmagnesium bromide alternately, instead of using the conventional method of producing iodide in an amount of 1.5 to 2.5 mol. Equivalent) can be used, and the amount of methyllithium or methylmagnesium bromide can also be reduced so that the target compound of Structural Formula (I) was obtained by an improved manufacturing method in terms of cost.

다음 실시예를 들어 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to the following examples.

실시예에 의하여 본 발명의 특허청구의 범위가 한정되는 것은 아니다.The scope of the claims of the present invention is not limited by the examples.

실시 예 1Example 1

시클로펜타데칸-1-온 에틸렌케탈의 합성(Ⅲ)Synthesis of cyclopentadecan-1-one ethylene ketal (III)

1 L 둥근 2 구 플라스크에 표제화합물(Ⅱ)인 시클로펜타데칸-1-온 50 g, 무수 시클로-헥산 500 ml, 에틸렌글리콜 200 ml, 파라-톨루엔설폰산수화물 4.24 g을 넣고 환류시킨다. 10 시간 후 실온으로 냉각시키고 분액여두를 사용하여 에틸렌글리콜층을 분리한다. 분리한 에틸렌글리콜층을 무수 시클로-헥산 50 ml로 추출하여 미리 분리한 시클로-헥산층과 합한 후 감압.유거하여 목적하는 표제화합물(Ⅲ)인무색의 기름상 고체를 순도 98∼99 %, 수율100 %(59.8 g)로 얻었다.Into a 1 L round two-necked flask, 50 g of the title compound (II) cyclopentadecan-1-one, 500 ml of anhydrous cyclo-hexane, 200 ml of ethylene glycol, and 4.24 g of para-toluenesulfonic acid hydrate were added to reflux. After 10 hours, the mixture was cooled to room temperature and an ethylene glycol layer was separated using a separatory filter. The separated ethylene glycol layer was extracted with 50 ml of anhydrous cyclo-hexane and combined with the previously separated cyclo-hexane layer, followed by distillation under reduced pressure. The colorless oily solid of the title compound (III) was obtained with a purity of 98-99%, yield. Obtained at 100% (59.8 g).

실시예 2Example 2

2-브로모시클로펜타데칸-1-온 에틸렌 케탈의 합성(Ⅳ)Synthesis of 2-bromocyclopentadecan-1-one ethylene ketal (IV)

1 L 3 구 플라스크에 500 ml 적하깔때기(dropping funnel)과 온도계를 달고 PTT 90.46 g을 무수 테트라히드로푸란 200 ml에 녹여 dropping funnel에 넣고 실시예 1에서 제조한 표제화합물(Ⅲ) 59.8 g을 무수 테트라히드로푸란 130 ml에 녹여 플라스크에 넣은 후 0 ℃를 유지시키고 PTT의 테트라히드로푸란용액을 2 시간동안 적가한다.500 ml dropping funnel and thermometer were added to a 1 L three-necked flask, 90.46 g of PTT was dissolved in 200 ml of anhydrous tetrahydrofuran and placed in a dropping funnel. 59.8 g of the titled compound (III) prepared in Example 1 was added to anhydrous tetra After dissolving in 130 ml of hydrofuran and placing it in the flask, the solution was kept at 0 ° C. and tetrahydrofuran solution of PTT was added dropwise for 2 hours.

PTT 테트라히드로푸란용액의 적가가 끝난 후 포화 중탄산나트륨용액 250 ml에 붓고 30 분간 교반한 후 테트라히드로푸란를 감압유거한 다음 얻은 잔류물을 노르말-헥산 50 ml씩 3 회 추출하고 노르말-헥산층을 포화소금물 50 ml로 씻어준다.After the dropwise addition of the PTT tetrahydrofuran solution, the mixture was poured into 250 ml of saturated sodium bicarbonate solution, stirred for 30 minutes, the tetrahydrofuran was distilled off under reduced pressure, the residue was extracted three times with 50 ml of normal-hexane, and the normal-hexane layer was saturated. Wash with 50 ml of brine.

유기층을 무수 황산마그네슘으로 건조시킨 후 감압유거하여 목적하는 표제화합물(Ⅳ)인 미황색의 기름상 물질을 순도 98 %, 수율 100 %(77.12 g)로 얻었다.The organic layer was dried over anhydrous magnesium sulfate and then distilled under reduced pressure to obtain a pale yellow oily substance as the title compound (IV), with a purity of 98% and a yield of 100% (77.12 g).

실시에 33 to implementation

2-시클로펜타데센-1-온 에틸렌 케탈의 합성(Ⅴ)Synthesis of 2-cyclopentadecene-1-one ethylene ketal (Ⅴ)

1 L 3 구 플라스크에 실시예 2에서 제조한 표제화합물(IV) 77.12 g, 디메칠설폭사이드 350 ml, 수산화나트륨 26.75 g 과 PEG-600 53.38 g 을 넣고 용액의 온도가 65∼70 ℃에서 7∼8 시간동안 격렬하게 교반시킨다.Into a 1 L three-neck flask, 77.12 g of the title compound (IV) prepared in Example 2, 350 ml of dimethyl sulfoxide, 26.75 g of sodium hydroxide and 53.38 g of PEG-600 were added, and the temperature of the solution was 7 to 7 to 65 to 70 ° C. Stir vigorously for 8 hours.

반응이 종료되면 포화소금물 1.5 L에 붓고 1N-염산 440 ml로 산성화한 후 노르말-헥산 100 ml로 3 회 추출하여 노르말-헥산층을 합한 후, 1N-수산화나트륨용액125 ml을 넣고 교반하여 생성된 오일상 고체를 여과하고 분액여두를 사용하여 얻은 노르말-헥산층을 감압, 유거하여 목적하는 표제화합물(Ⅴ)인 황갈색 기름상 물질을 순도 99 %, 수율 99 %(58.7 g)로 얻었다.After the reaction was completed, poured into 1.5 L of saturated brine, acidified with 440 ml of 1N hydrochloric acid, extracted three times with 100 ml of normal-hexane, and then combined the normal-hexane layer. Then, 125 ml of 1N-sodium hydroxide solution was added to the mixture, and the resulting mixture was stirred. The oily solid was filtered and the normal-hexane layer obtained using the separating filter was distilled off under reduced pressure to obtain a yellowish brown oily substance as the title compound (V) with a purity of 99% and a yield of 99% (58.7 g).

실시예 4Example 4

2-시클로펜타데센-1-온의 합성(Ⅵ)Synthesis of 2-cyclopentadeceen-1-one (Ⅵ)

2 L 1 구 플라스크에 실시예 3에서 제조한 표제화합물(Ⅴ) 58.7 g, 아세톤 110 ml, 물 19 ml, 황산마그네슘 3.25 g, 옥살산 수화물 2.0 g을 넣고 실온에서 4∼5 시간동안 교반시킨다.Into a 2 L one-neck flask, add 58.7 g of the title compound (V) prepared in Example 3, 110 ml of acetone, 19 ml of water, 3.25 g of magnesium sulfate, and 2.0 g of oxalic acid hydrate, and stir at room temperature for 4 to 5 hours.

반응이 종료되면 아세톤을 감압유거한 후 잔사에 물 100 ml를 넣고 노르말-헥산 100 ml씩 3 회 추출한다.After the reaction was completed, acetone was distilled off under reduced pressure, 100 ml of water was added to the residue, and 100 ml of normal-hexane was extracted three times.

노르말-헥산층을 포화소금물 100 ml와 물 100 ml로 씻어주고 무수 황산마그네슘으로 건조한 후 감압유거하여 목적하는 표제화합물(Ⅵ)인 황갈색 기름상의 물질을 순도 97 %, 전체수율 98 %(48.5 g)로 얻었다.The normal-hexane layer was washed with 100 ml of saturated salt water and 100 ml of water, dried over anhydrous magnesium sulfate, and then distilled under reduced pressure to obtain a yellowish brown oily substance, the title compound (VI), with a purity of 97% and a total yield of 98% (48.5 g). Got it.

실시예 5Example 5

디엘-3-메칠-시클로펜타데칸-1-온의 합성(Ⅰ)Synthesis of DL-3-Methyl-cyclopentadecan-1-one (Ⅰ)

3 L 3 구 플라스크에 보정된 250 ml dropping funnel과 온도계를 장치하고 질소로 충진한 후 무수톨루엔 25 ml과 요오드화제일동 10.4 g을 넣고 0 ℃를 유지시키면서 1.4 M 메칠리튬 78 ml를 가하고 무수 톨루엔 170 ml로 희석한 무색의 디메칠쿠퍼리튬용액을 만든다.A 3 L three-necked flask was equipped with a calibrated 250 ml dropping funnel and a thermometer, filled with nitrogen, 25 ml of anhydrous toluene and 10.4 g of iodide dilute, and 78 ml of 1.4 M methyllithium was maintained at 0 ° C. and toluene 170 Prepare a colorless Dimethyl Cooper Lithium solution diluted in ml.

상기 반응용액의 온도를 -20 ℃로 유지시킨다. 여기에 실시예 4에서 제조한 표제화합물(Ⅵ) 48.5 g을 무수톨루엔 50ml에 용해시켜 적가하되, 하기와 같이 첨가한다. 톨루엔에 용해시킨 용액을 dropping funnel에 넣고 표제화합물(Ⅵ)의 1/4 분량을 30 분간 적가하고, 다시 1.4 M 메칠리튬 39 ml를 첨가하고 표제화합물(Ⅵ)의 1/4 분량을 30 분간 적가한다.The temperature of the reaction solution is maintained at -20 ° C. Here prepared in Example 4 48.5 g of the title compound (VI) was added dropwise while dissolved in 50 ml of anhydrous toluene, and added as follows. The solution dissolved in toluene was added to a dropping funnel, and a 1/4 portion of the title compound (VI) was added dropwise for 30 minutes, again, 39 ml of 1.4 M methyllithium was added, and a 1/4 portion of the title compound (VI) was added dropwise for 30 minutes. do.

이후 위의 1.4 M 메칠리튬 39 ml를 첨가하고 표제화합물(Ⅵ)의 1/4 분량을 30 분간 적가하는 첨가조작을 2회 반복하여 얻은 용액을 포화 암모늄클로라이드용액 500 ml에 붓고, 28 % 암모니아수 60 ml을 첨가하고 1 시간동안 교반하여 만든 용액을 노르말-헥산 50 ml씩으로 3 회 추출한다.Thereafter, 39 ml of 1.4 M methyllithium was added thereto, and the obtained solution was repeatedly added twice to add 1/4 portion of the title compound (VI) for 30 minutes, and then poured into 500 ml of saturated ammonium chloride solution, and 28% aqueous ammonia 60 ml is added and the resulting solution is stirred three times with 50 ml of normal-hexane.

노르말-헥산층을 20 % 암모니아수 50 ml, 물 50 ml, 포화 소금물 50 ml 순으로 씻어주고 무수 황산마그네슘으로 건조하여 감압, 유거하여 미황색의 목적하는 표제화합물(I, 디엘-3-메칠-시클로펜타데칸-1-온)을 순도 94∼96 %, 수율 98 % (52.6 g)로 얻었다.The normal-hexane layer was washed with 50 ml of 20% ammonia water, 50 ml of water, and 50 ml of saturated brine, dried over anhydrous magnesium sulfate, and dried under reduced pressure and distilled to give the title compound (I, DL-3-methyl-cyclopenta) as light yellow. Decan-1-one) was obtained with a purity of 94-96%, yield 98% (52.6 g).

본 발명에 따르면, 인체에 유해성이 큰 용매의 사용을 회피하여 반응공정상의 안정성을 확보하고, 반응시간을 단축시키며, 알콜사이드 또는 요오드화제일동등의 고가시약의 사용이 필요없거나 사용량을 줄임으로서, 제조원가면에서 향상된 공정으로, 상기 구조식(Ⅰ)의 화합물을 안전하고 저렴하게 고수율, 고순도를 유지하며, 공업적으로 대량생산이 가능하다는 특장점이 있어, 본 발명은 산업적으로 매우 유용한 발명임을 알 수 있다.According to the present invention, by avoiding the use of a solvent that is harmful to the human body to ensure the stability of the reaction process, to shorten the reaction time, eliminating the need or use of expensive reagents, such as alcohol side or iodide iodide, As an improved process in the mask, the compound of formula (I) is safe and inexpensive to maintain high yield, high purity, and industrially mass production is possible, the present invention can be seen that the invention is very useful industrially .

Claims (6)

출발물질인 구조식(Ⅱ)의 시클로펜타데칸-1-온 화합물을 무수 시클로-헥산, 파라-톨루엔설폰산 촉매하에서 가열하여 생성되는 물을 제거하면서 케탈화 반응을 진행하여 구조식(Ⅲ)의 시클로펜타데칸-1-온 에틸렌케탈 화합물을 제조하고, 얻어진 구조식(Ⅲ) 화합물을 무수 테트라히드로푸란 중에서 페닐트리메칠암모늄트리브로마이드를 사용하여 구조식(Ⅳ)의 2-브로모시클로펜타데칸-1-온 에틸렌케탈 화합물을 제조한후, 얻은 구조식(Ⅳ) 화합물을 디메칠 설폭사이드와 PEG 존재하에서 수산화나트륨을 사용하여 구조식(Ⅴ)의 2-시클로펜타데센-1-온 에틸렌케탈 화합물을 제조한 다음, 얻어진 구조식(Ⅴ) 화합물을 실온에서 아세톤과 물 중에서 황산마그네슘과 옥살산 수화물을 산촉매로 사용하여 구조식(Ⅵ)의 2-시클로펜타데센-1-온 화합물을 제조하고, 이어서 제조한 구조식(Ⅵ)의 화합물을 -40∼0 ℃의 무수 톨루엔중에서 요오드화제일동을 촉매로 사용하면서 교대로 구조식(VI)화합물을 0.25 당량씩 4회 첨가하고, 메칠리튬 또는 메칠마그네슘 브로마이드를 구조식(VI)화합물 1몰에 대하여 0.25~0.62 당량씩 4회 첨가하여 반응시키되, 메칠리튬 또는 메칠마그네슘브로마이드를 각각 먼저가한후 구조식(VI)화합물을 교대로 첨가함을 특징으로하는 구조식(Ⅰ)의 디엘-3-메칠-시클로펜타데칸-1-온 화합물을 제조하는 방법.The cyclopentadecane-1-one compound of formula (II), which is a starting material, was heated under anhydrous cyclo-hexane and para-toluenesulfonic acid catalyst, followed by a ketalization reaction to remove the water, thereby forming a cyclopenta of formula (III). A decan-1-one ethylene ketal compound was prepared and 2-bromocyclopentadecan-1-one ethylene of the formula (IV) was prepared by using phenyltrimethylammonium tribromide in anhydrous tetrahydrofuran. After preparing the ketal compound, the obtained compound of formula (IV) was prepared by using sodium hydroxide in the presence of dimethyl sulfoxide and PEG to prepare 2-cyclopentadeceen-1-one ethylene ketal compound of formula (V), and then The 2-cyclopentadeceen-1-one compound of formula (VI) was prepared by using the compound of formula (V) at room temperature in magnesium acetate and oxalic acid hydrate in acetone and water as acid catalysts. Using the compound of formula (VI) prepared in -40 to 0 ℃ anhydrous toluene as a catalyst, alternating addition of the compound of formula (VI) four times, each 0.25 equivalents, and methyllithium or methylmagnesium bromide The reaction is performed by adding 0.25 ~ 0.62 equivalents four times with respect to 1 mol of the compound of formula (VI), followed by the addition of methyllithium or methylmagnesium bromide first, followed by alternating addition of the compound of formula (VI) To prepare a DL-Methyl-cyclopentadecan-1-one compound. 제1항에 있어서, 수산화나트륨의 사용량을 구조식(Ⅳ)의 화합물 1몰에 대하여 2∼3배 몰을 사용하며, 반응온도를 65∼70 ℃로 사용하는 방법.The method according to claim 1, wherein the amount of sodium hydroxide is used 2 to 3 times mole with respect to 1 mole of the compound of the formula (IV), and the reaction temperature is used at 65 to 70 ° C. 제1항에 있어서, 폴리에틸렌글리콜(PEG)는 PEG-400, -600, -4000, -6000 중에서 1종을 선택사용하고, 그 사용량을 구조식(Ⅳ)의 화합물 1몰에 대하여 30∼50배 몰 %을 사용하는 방법.The polyethylene glycol (PEG) is one selected from PEG-400, -600, -4000, -6000, and the amount of the polyethylene glycol (PEG) is 30 to 50 times molar with respect to 1 mol of the compound of the formula (IV) How to use%. 제1항에 있어서, 황산마그네슘과 옥살산수화물의 사용량을 구조식(V)화합물 1몰에 대하여 각각 10배 몰 %씩 사용하는 방법.The method according to claim 1, wherein the amount of magnesium sulfate and oxalate hydrate is used in an amount of 10 times mole% each with respect to 1 mole of the compound of formula (V). 제1항에 있어서, 촉매인 요오드화 제일동을 구조식(VI)화합물 1당량에 대하여 0.25∼0.32 당량의 비율로 사용하는 방법.The method according to claim 1, wherein the first copper iodide as a catalyst is used in a ratio of 0.25 to 0.32 equivalents based on 1 equivalent of the compound of formula (VI). 삭제delete
KR10-1999-0065777A 1999-12-30 1999-12-30 A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE KR100369410B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-1999-0065777A KR100369410B1 (en) 1999-12-30 1999-12-30 A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-1999-0065777A KR100369410B1 (en) 1999-12-30 1999-12-30 A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE

Publications (2)

Publication Number Publication Date
KR20010065821A KR20010065821A (en) 2001-07-11
KR100369410B1 true KR100369410B1 (en) 2003-01-24

Family

ID=19632946

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-0065777A KR100369410B1 (en) 1999-12-30 1999-12-30 A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE

Country Status (1)

Country Link
KR (1) KR100369410B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5585536A (en) * 1978-12-25 1980-06-27 Nippon Zeon Co Ltd Preparation of 3-methyl-2-cyclopentadecen-1-one
JPH07267968A (en) * 1994-03-30 1995-10-17 Takasago Internatl Corp Method for producing (z)-3-methyl-2-cyclopentadecene-1-one
KR0134387B1 (en) * 1994-09-13 1998-04-20 박대규 Process for producing d,l-3-methyl-cyclopentadecane-1- one
KR100195888B1 (en) * 1996-06-29 1999-06-15 박대규 Process for producing d,l-3-methyl-cyclopentadecan-1-one

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5585536A (en) * 1978-12-25 1980-06-27 Nippon Zeon Co Ltd Preparation of 3-methyl-2-cyclopentadecen-1-one
JPH07267968A (en) * 1994-03-30 1995-10-17 Takasago Internatl Corp Method for producing (z)-3-methyl-2-cyclopentadecene-1-one
KR0134387B1 (en) * 1994-09-13 1998-04-20 박대규 Process for producing d,l-3-methyl-cyclopentadecane-1- one
KR100195888B1 (en) * 1996-06-29 1999-06-15 박대규 Process for producing d,l-3-methyl-cyclopentadecan-1-one

Also Published As

Publication number Publication date
KR20010065821A (en) 2001-07-11

Similar Documents

Publication Publication Date Title
KR100249448B1 (en) Preparation of arthropodicidal oxadiazines
EP3712130B1 (en) Method for synthesis of roxadustat and intermediate compounds thereof
KR20010006074A (en) Asymmetric Synthesis of Benzoxazinones via New Intermediates
HU185789B (en) Process for preparing new 3-phenoxy-4-fluoro-benzaldehyde-acetal derivatives
KR101502322B1 (en) Process for the preparation of pure anastrozole
KR100369410B1 (en) A PROCESS FOR THE PREPARATION OF d,l-3-METHYL-CYCLOPENTADECAN-1-ONE
WO2012153162A1 (en) Novel method for preparation of atovaquone
US4450297A (en) Preparation of o-nitrobenzaldehyde
JPS6133829B2 (en)
HU182693B (en) Process for producing 4-fluoro-3-phenoxy-thoulene
KR20010049460A (en) Process for producing retinal and intermediates for producing the same
US6147226A (en) Synthesis of cyclopentyl 2-thienyl ketone, tiletamine and tiletamine acid addition salts, such as tiletamine hydrochloride
CN114773309B (en) Preparation method and application of 1- (7-halobenzo [ D ] [1,3] dioxan-4-yl) alkyl ketone compound
EP1070038B1 (en) New processes for the preparation of 3-bromoanisole and 3-bromonitrobenzene
US20090192321A1 (en) Process for producing 2-benzoyloxyacetaldehyde derivative
KR100203457B1 (en) Process for terbinafine
JPH1121275A (en) Production of aminonitrile derivative
US5969159A (en) Synthesis of cyclopentyl 2-thienyl ketone tiletamine and tiletamine acid addition salts such as tiletamine hydrochloride
Roy et al. A novel process for synthesis of Atovaquone
KR100195888B1 (en) Process for producing d,l-3-methyl-cyclopentadecan-1-one
JPS6113694B2 (en)
JPH0761978B2 (en) Manufacturing method of glutaric acid derivative
KR100208427B1 (en) A process for producing d, l, -3-methyl-cyclopentadecan-1-one
KR910001236B1 (en) Process for the preparation of 2-(4-amino phenyl0-2-methyl propyl alcohol
JPH0439449B2 (en)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130109

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20140106

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee